With precapillary pulmonary hypertension confirmed by pulmonary artery catheterization
With an indication for pulmonary artery vasodilator treatment
Affiliation with a social security system
Women of childbearing age using effective/highly effective contraception (see CTFG) (estrogen-progestogen or intrauterine device or tubal ligation) for 6 months and a negative urine pregnancy test at inclusion, for the duration of the study.
Postmenopausal women: confirmed diagnosis (non-medically induced amenorrhea for at least 12 months prior to the inclusion visit)
Individuals who have read and understood the information letter and signed the consent form
Treatment with non-invasive ventilation
Eisenmenger syndrome
Systemic scleroderma
Neurodegenerative disease other than isolated peripheral neuropathies.
Untreated and/or uncontrolled cardiac rhythm or conduction disorders, including permanent AF
Untreated coronary artery disease or diagnosis of myocardial infarction within the last six months
Pacemaker wearer
Pregnant or breastfeeding women, or women who are not using reliable contraception
Persons deprived of their liberty by administrative or judicial decision or persons under judicial protection/guardianship or curatorship
History of psychological or sensory illness or abnormality that may prevent the subject from fully understanding the conditions required for participation in the protocol or prevent them from giving their informed consent
Clareo Health | Evolution of Hypoxic Burden and Sympathetic/Parasympathetic Balance in Patients With Pulmonary Hypertension
